May 8, 2012
Eleven Biotherapeutics Secures $20 Million and Expands Series A Financing » Press Release | Company News
May 8, 2012
Oncology Expert George Demetri, M.D., Joins Blueprint Medicines as a Clinical Advisor » Press Release | Company News
our approach
"When I transitioned into Third Rock, the team spent hours with me making sure that I knew the strategy, business plan, people and goals. The former Third Rock management team was very available and provided a ton of support, but at the same time, as much space as I needed. I consider this experience the optimal transition from a VC-led team to the newly appointed management team."
Abbie Celniker, Ph.D. CEO of Eleven Biotherapeutics
At Third Rock we seek bold ideas and new frontiers that will pave the way for disruptive technologies and innovative science that promise to dramatically improve the lives of patients.
We do that by actively engaging and collaborating with entrepreneurs and industry partners to build, launch and operate our portfolio companies. Where needed, we may initially serve in key management roles in order to establish a solid foundation for the entrepreneur’s strategic vision, market knowledge, scientific expertise and/or social capital to accelerate the forward momentum of a company. We will also work with and support outstanding leadership teams that may already be in place. In all cases, we support portfolio companies in a range of areas, including:
Providing Strategic and Operational Leadership:
Third Rock’s unique approach is grounded in senior capabilities in commercial, business development, R&D, drug discovery and product development, which we leverage in support of launching and building transformative life sciences companies. As successful business people and entrepreneurs with extensive operational backgrounds, we partner with portfolio companies across multiple functions to translate scientific innovation into the reality of breakthrough medical products.
Building Leadership and a Culture of Integrity
We recruit outstanding leadership at the management, board and advisory levels and nurture strong corporate cultures within our portfolio companies. Through leadership summits and career development programs, we are committed to the personal and professional success of the management of our portfolio companies.
Offering R&D Insight
We work at the intersection of science and business – developing a robust, real-world roadmap to advance novel products and devices and building upon our experience across the drug and medical device spectrum in multiple therapeutic areas.
Supporting Business Development Our team actively facilitates licensing and strategic opportunities with pharmaceutical and device companies by leveraging our track record of leading more than 500 collaborations, and creating more than $13 billion in value, along with our strong network of relationships with leaders at pharmaceutical companies worldwide. Collaborations with large life sciences companies are a key part of our unique strategy, as we can deliver innovation to their pipelines with new and exciting products and in return build our companies in a more capital efficient manner.
